Compounded semaglutide and tirzepatide are prepared by licensed 503A compounding pharmacies based on individual, patient-specific prescriptions
Scott Butsch, director of obesity medicine at the Cleveland Clinic Bariatric and Metabolic Institute
GLP-1 has a direct effect on adipose tissue
Large meals overwhelm a stomach that semaglutide is deliberately slowing down
The documentation your insurer typically wants includes a recorded BMI meeting the threshold (30 or above, or 27 with comorbidities), proof of at least one qualifying comorbidity, evidence of previous weight loss attempts (usually 3-6 months of documented lifestyle intervention), current lab work showing relevant metabolic markers, and a letter of medical necessity from your prescribing physician
By leveraging cutting-edge treatments like Semaglutide GLP-1, we aim to enhance the quality of life for our patients managing type 2 diabetes, helping them achieve better health outcomes